Hope for patients with neoplastic disease and invasive fungal infections.
McLeroth
Patrick
P
HIV Medicine, Chase Brexton Health Services, Baltimore, Maryland, USA.
Polsky
Bruce
B
D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D054714:Echinocandins; D006801:Humans; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D009369:Neoplasms / Q000150:complications* / Q000382:microbiology*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D000077336:Caspofungin; D065819:Voriconazole